SAL-023

N/A

Report date: 2025/09/19 13:23:26

Base Information

Drug NameSAL-023
Drug Alias Name泰卡西单抗SAL-023
ClassificationBiologics > Biosimilar
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Genemen Biotech Co LtdXinlitai (Chengdu) Biological Technology Co LtdShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoporosis, PostmenopausalOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A